Loading company…
OriCiro Genomics develops cell-free DNA assembly and amplification technologies and research kits.
Founded in 2018 and based in Tokyo, OriCiro Genomics develops tools for assembling and amplifying circular DNA without cell culture. Its products include the OriCiro Cell-Free Cloning System, with separate assembly and amplification kits. In July 2021, the company received JPY 800 million in Series B funding from UTEC and ITOCHU Technology Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in